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In the absence of established guidelines for hospital-
ization of patients with pandemic (H1N1) 2009, we studied 
emergency department patients to identify clinical parame-
ters that predict need for hospitalization. Independent pre-
dictors of hospitalization include multiple high-risk medi-
cal conditions, dyspnea, and hypoxia. These ﬁ  ndings are 
easily applicable, with a 79% positive predictive value for 
hospitalization.
P
ast inﬂ  uenza outbreaks have shown that limited health-
care resources may be rapidly overwhelmed during an 
outbreak (1,2). Guidelines for hospitalization of persons with 
inﬂ  uenza would help physicians by providing a framework 
for the initial evaluation and management of patients with 
inﬂ  uenza. We conducted a study of patients with pandemic 
(H1N1) 2009 to identify predictors for hospitalization.
The Study
All patients with conﬁ  rmed pandemic (H1N1) 2009 
infection seen in the emergency department (ED) of Rush 
University Medical Center (a 613-bed teaching hospital 
in Chicago) from April 29, 2009, through June 22, 2009, 
were included in the study. Patients were stratiﬁ  ed into 
2 groups: hospitalized patients (admitted for at least 24 
hours) and nonhospitalized patients (patients discharged 
from the ED). 
Respiratory specimens from ED patients with inﬂ  u-
enza-like illness were tested by reverse transcription–PCR 
for respiratory viruses by using the Luminex xTAG RVP 
(Luminex, Austin, TX, USA), and clinical data were en-
tered into electronic medical records. Specimens positive 
for nontypeable inﬂ  uenza A by Luminex xTAG RVP were 
conﬁ  rmed as pandemic (H1N1) 2009 by using the Centers 
for Disease Control and Prevention (CDC) reverse tran-
scription–PCR for pandemic (H1N1) 2009 (3). Continuous 
variables that vary with age (respiratory rate, blood pres-
sure, hematologic counts) were regrouped as normal or ab-
normal by using age-speciﬁ  c normal ranges (4,5). Obesity 
(body mass index >30) for adults and children 2–19 years 
of age and for those with high-risk medical conditions was 
deﬁ  ned according to CDC guidelines (6,7).
The Mann-Whitney U test and Pearson χ2 test or Fisher 
exact test were used to compare continuous and categori-
cal variables, respectively. p values <0.05 were considered 
signiﬁ   cant. Backwards stepwise logistic regression was 
performed for factors associated with hospitalization and 
intensive care unit (ICU) admission. Goodness-of-ﬁ  t was 
determined with the Hosmer-Lemeshow statistic. Data were 
analyzed by using SPSS version 16.0 (SPSS Inc., Chicago, 
IL, USA). The study was approved by the institutional re-
view board of Rush University Medical Center.
A total of 189 cases that were identiﬁ  ed by review 
of microbiology records were considered eligible for the 
study. However, only 83 patients who were examined in the 
ED were included in the study; the remaining 106 patients 
were seen at outpatient clinics and private doctors’ ofﬁ  ces. 
Demographic, clinical, and laboratory data of hospitalized 
patients (32 [39%]) were compared with data from those 
discharged from the ED (51 patients) (Tables 1, 2).
Most patients were African American (63%) or His-
panic (27%); 48 patients (58%) were female. The median 
age of hospitalized patients was 12 years (interquartile 
range 2–38.8 years) versus 20 years (interquartile range 
9–28 years) for nonhospitalized patients (p = 0.70). Of 32 
hospitalized patients, 17 (53%) were children; most (71%) 
of these children were <5 years of age. The most common 
admitting diagnoses were pneumonia (11 patients), viral 
syndrome (5 patients), inﬂ  uenza (4 patients), and asthma 
exacerbation (4 patients). Univariate analysis showed that 
being <5 years of age was signiﬁ  cantly associated with 
hospitalization (38% hospitalized vs. 16% nonhospitalized, 
odds ratio 3.2, 95% conﬁ  dence interval 1.1–9.1; p = 0.02).
Hospitalized patients were signiﬁ  cantly more likely 
to report a high-risk medical condition than were nonhos-
pitalized patients (p<0.0001). Univariate analysis showed 
that the following high-risk medical conditions were also 
signiﬁ  cantly associated with hospitalization: history of pre-
maturity, hemoglobinopathy, and chronic neurologic dis-
ease (p<0.05). A trend toward a higher incidence of chronic 
pulmonary disease was seen in hospitalized patients (41% 
vs. 22% of nonhospitalized patients; p = 0.06). Obesity was 
not found to be a signiﬁ  cant risk factor for hospitalization 
(p = 0.18).
Patients with dyspnea were signiﬁ  cantly more likely to 
be hospitalized (p<0.0001). Hospitalized patients had low-
er pulse oximeter oxygen saturation (SpO2; median 95%, 
range 65%–100%) than nonhospitalized patients (median 
99%, range 96%–100%; p<0.0001). Tachypnea and hy-
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poxia (SpO2 <92%) were signiﬁ  cantly associated with hos-
pitalization (p = 0.002 and p<0.0001, respectively). Five 
of 39 patients with measured creatinine had evidence of 
acute renal failure, which was signiﬁ  cantly associated with 
hospitalization (p = 0.007). A chest radiograph showed an 
inﬁ  ltrate in 11 of 51 patients, and all 11 patients were hos-
pitalized (p = 0.001). Hypoxia was a strong predictor of a 
chest radiograph ﬁ  nding of inﬁ  ltrate (odds ratio 50.7, 95% 
conﬁ   dence interval 7.2–354.3; p<0.0001). Multivariate 
analysis showed that high-risk medical conditions (median 
number of high-risk conditions 2 vs. 0; p = 0.01), dyspnea 
(p = 0.01), and oxygen saturation (median SpO2 95% vs. 
99%; p = 0.004) were found to be signiﬁ  cantly associated 
with hospitalization (online Appendix Table 1, www.cdc.
gov/EID/content/16/10/1594-appT1.htm).
Sixteen of 83 (19%) study patients were admitted to 
an ICU. No deaths occurred. Univariate analysis showed 
that the following factors were signiﬁ  cantly associated with 
ICU admission: greater median number of high-risk medi-
cal conditions (2 vs.1; p<0.0001), patient age <5 years (p 
= 0.002), chronic pulmonary disease (p = 0.01), history of 
prematurity (p = 0.001), congenital heart disease (p = 0.04), 
dyspnea (p<0.0001), tachypnea (p = 0.003), lower median 
oxygen saturation (SpO2 92% vs. 98%; p <0.0001), acute 
renal failure (p = 0.004), and an inﬁ  ltrate on chest radio-
graph (p<0.0001). Multivariate analysis showed that dys-
pnea (p = 0.01) and oxygen saturation (median SpO2 92% 
vs. 98%; p = 0.02) were signiﬁ  cantly associated with ICU 
admission (online Appendix Table 2, www.cdc.gov/EID/
content/16/10/1594-appT2.htm).
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Table 1. Demographics of nonhospitalized and hospitalized patients who had pandemic (H1N1) 2009 infection, Rush University 
Medical Center, Chicago, Illinois, USA, April 29–June 22, 2009* 
Characteristic
Nonhospitalized
patients, n = 51
Hospitalized
patients,
n = 32 
ICU patients,
n = 16 
Nonhospitalized vs. 
hospitalized patients
ICU vs. non–ICU 
patients†
p value 
OR
(95% CI)  p value 
OR
(95% CI) 
Median age, y (IQR)  20.0  
(9.0–28.0) 
12.0
(2.0–38.8) 
2.5
(1.13–31.8) 
0.70‡ – 0.16‡  –
Age <5 y, no. (%)  8 (15.7)  12 (37.5)  9 (56.3)  0.02§  3.2
(1.1–9.1) 
0.002 6.6   
(2.0–21.3) 
Sex, M/F (% M)  23/28 (45.1)  12/20 (37.5) 5/11 (31.3)  0.50§  0.73  
(0.30–1.8) 
0.33§ 0.56   
(0.18–1.8) 
Presence of high- risk 
conditions,¶ no. (%) 
21 (41.2)  29 (90.6)  16 (100)   <0.0001§  13.8  
(3.7–51.3)    <0.0001 –
No. high-conditions per patient,¶ 
median (range) 
0 (0–2)  2 (0–4)  2 (1–3)  <0.0001‡# – <0.0001‡ –
Chronic pulmonary disease, no. 
(%) 
11 (21.6)  13 (40.6)  9 (56.3)  0.06§  2.5
(0.94–6.6) 
0.01 4.5  
(1.4–14.0) 
History of prematurity, no. (%)  0 6 (18.8)  5 (31.3)  0.002  – 0.001  30.0  
(3.2–281.8)
Congenital heart disease,** no. 
(%) 
0 2 (6.3)  2 (12.5)  0.15 – 0.04 –
Transplantation,†† no. (%)  1 (2.0)  3 (9.4)  1 (6.3)  0.29 5.2
(0.51–52.1) 
1.00 1.4  
(0.14–14.6)
Hemoglobinopathy, no. (%)  0 4 (12.5)  2 (12.5)  0.02 – 0.17 4.6
(0.6–35.8) 
Diabetes mellitus, no. (%)  3 (5.9)  5 (15.6)  3 (18.8)  0.25 3.0
(0.66–13.4) 
0.18 2.9  
(0.6–13.5) 
Chronic neurologic disease  2 (3.9)  7 (21.9)  4 (25.0)  0.02 6.9
(1.3–35.5) 
0.07 4.1  
(1.0–17.7) 
Immunosuppression, no. (%)  2 (3.9)  5 (15.6)  3 (18.8)  0.10 4.5
(0.82–25.0) 
0.13 3.6  
(0.7–18.2) 
Malignancy, no. (%)  0 3 (9.4)  1 (6.3)  0.054  – 0.48 2.2
(0.2–25.5) 
Pregnancy, no. (%)‡‡  1 (4)  3 (15.0)  0 0.29 4.8
(0.46–49.6) 
0.56 –
*p values by Fisher exact test except as indicated. ICU, intensive care unit; OR, odds ratio; CI, confidence interval; IQR, interquartile range; –, not 
applicable. 
†Nonhospitalized patients + hospitalized patients not in ICU; n = 67. 
‡Mann-Whitney U test. 
§Pearson 2-sided Ȥ
2 test. 
¶High-risk conditions as defined by Centers for Disease Control and Prevention: <5 y or >65 y; pregnancy; immunosuppression; chronic pulmonary, 
cardiovascular, hepatic, hematologic, neurologic, neuromuscular, or metabolic disorders; long-term aspirin therapy in those <18 y of age. 
 #Significant on multivariate analysis. 
**Tetralogy of Fallot (1), patent ductus arteriosus status postmedical closure (1). 
†† Renal transplant (2), liver transplant (1), heart transplant (1). 
‡‡Percentage of female patients. Conclusions
We sought to identify predictors of hospitalization in 
patients with conﬁ  rmed pandemic (H1N1) 2009 infection. 
Univariate analysis showed that presence of high-risk 
medical conditions, age <5 years, dyspnea, and ﬁ  ndings 
of tachypnea, hypoxia (SpO2 <92%), chest radiograph in-
ﬁ  ltrate, and acute renal failure were signiﬁ  cant risk fac-
tors for hospitalization. Notably, headache, rhinorrhea, 
sore throat, and cough were inversely associated with 
hospital admission. We hypothesize that treating phy-
sicians perceive these symptoms as more suggestive of 
upper respiratory tract disease and hence are less likely to 
hospitalize such patients.
Multivariate analysis showed that only a higher number 
of high-risk medical conditions (including age <5 years), 
dyspnea, and a lower median oxygen saturation level were 
predictive of hospitalization. We found that dyspnea and a 
low median oxygen saturation level were also associated 
with ICU admission. These ﬁ  ndings suggest that clinicians’ 
decision to hospitalize was not inﬂ  uenced by mere percep-
tion of illness severity, but rather it accurately reﬂ  ected the 
risk for complicated or severe disease. Our ﬁ  ndings are also 
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Table 2. Clinical characteristics of nonhospitalized and hospitalized patients who had pandemic (H1N1) 2009 infection, Rush 
University Medical Center, Chicago, Illinois, USA, April 29–June 22, 2009* 
Characteristic
Nonhospitalized
patients, n = 51 
Hospitalized
patients,
n = 32 
ICU patients,
n = 16 
Nonhospitalized vs. 
hospitalized patients 
ICU vs. non–ICU 
patients†
p value
OR
(95% CI)  p value 
OR
(95% CI) 
Duration of ILI before 
evauulation, d, median (range) 
2 (0–7)  3 (1–7)  3 (1–7)  0.15‡  – 0.20‡  –
Subjective fever, no. (%)  46 (90.2)  27 (84.4)  14 (87.5)  0.50 0.59  
(0.16–2.2) 
1.00 0.95  
(0.18–5.0) 
Headache, no. (%)  18 (35.3)  5 (15.6)  1 (6.3)  0.05§  0.34  
(0.11–1.0) 
0.03 0.14  
(0.02–1.1) 
Cough, no. (%)  50 (98.0)  25/31 (80.7)  14 (87.5)  0.01 0.08  
(0.01–0.73) 
0.62 0.57  
(0.10–3.3) 
Rhinorrhea, no. (%)  40 (78.4)  13/31 (41.9)  7 (43.8)  0.001§  0.20  
(0.08-0.53) 
0.05§ 0.34   
(0.11–1.0) 
Sore throat, no. (%)  24 (47.1)  2/31 (6.5)  1 (6.3)  <0.0001§  0.08  
(0.02–0.36) 
0.02§ 0.11   
(0.01–0.88)
Myalgia, no. (%)  21 (41.2)  6/31 (19.4)  2 (12.5)  0.04§  0.34  
(0.12–0.98) 
0.053§ 0.23   
(0.05–1.1) 
Dyspnea, no. (%)  2 (3.9)  15 (46.9)  11(68.8)  <0.0001§¶ 21.6  
(4.5–104.4) 
<0.0001¶ 22.4  
(5.8–86.2) 
Nausea/vomiting, no. (%)  14 (27.5) 
 
9/31 (29.0)  4 (25.0)  0.88§  1.1
(0.40–2.9) 
1.00 0.83  
(0.24–2.9) 
Obesity (BMI >30 or weight 
>95th percentile), no. (%) 
12/37 (32.4)  11/22 (50.0)  4/10 (40.0)  0.18§  2.1
(0.71–6.2) 
1.00 1.1  
(0.26–4.2) 
Tachypnea, no. (%)  9/49 (18.4)  16/31 (51.6)  10 (62.5) 
 
0.002§ 4.7   
(1.7–13.0) 
0.003§ 5.4   
(1.7–17.5) 
O2 saturation, % (range)  99 (96–100)  95 (65–100)  92 (65–100)  <0.0001‡¶ – <0.0001‡¶ –
Hypoxia (SpO2 <92%), no. (%)  0 10 (31.3) 
 
9 (56.3)  <0.0001  – <0.0001  84.9  
(9.3–772.0)
Lymphopenia,# no. (%) 
 
9/12 (75.0)  21 (65.6)  10 (62.5)  0.72 0.64  
(0.14–2.80) 
0.54§ 0.67   
(0.18–2.5) 
Thrombocytopenia,# no. (%)  1/12 (8)  8 (25.0)  5 (31.3) 
 
0.41 3.70  
(0.41–33.00) 
0.25 2.7  
(0.6–12.2) 
Acute renal failure,** no. (%)  0 5 (15.6)  4 (25.0)  0.007  – 0.004 22.0   
(2.3–214.2)
Infiltrate on chest radiograph, 
no. (%) 
0 11/29 (37.9)  11 (68.9)  0.001  – <0.0001  –
*p values by Fisher exact test except as indicated. Values given as no./no. indicate number of patients for whom results were available (if less than total 
no. patients in category). ICU, intensive care unit; OR, odds ratio; CI, confidence interval; ILI, influenza-like illness; –, not applicable; BMI, body mass 
index; SpO2, pulse oximeter oxygen saturation.  
†Nonhospitalized patients + hospitalized patients not in ICU; n = 67. 
‡Mann-Whitney U test. 
§Pearson 2-sided Ȥ
2 test. 
¶Significant on multivariate analysis. 
#Lymphopenia <1,500 lymphocytes/mm
3, thrombocytopenia <150,000 thrombocytes/mm
3.
**Assuming that patients who did not have biochemical testing did not have acute renal failure. Hospitalization and Pandemic (H1N1) 2009
consistent with CDC alerts on emergency warning signs of 
pandemic (H1N1) 2009 inﬂ  uenza (8) and a recent report by 
Echevarría-Zuno et al. (9) from Mexico in which dyspnea, 
tachypnea, and cyanosis were prognostic factors for admis-
sion and death. Although the presence of any 1 underlying 
high-risk medical condition has been previously described 
as a risk factor for complication with seasonal inﬂ  uenza 
including hospitalization (10), a higher number of high-risk 
medical conditions is a stronger predictor of hospitalization 
(median number 2 vs. 0; p = 0.01). 
Although excellent clinical prediction rules for hos-
pitalization of patients with community-acquired pneu-
monia are available (e.g. CURB-65 or pneumonia sever-
ity index), few data exist for inﬂ  uenza admissions (10,11). 
We propose a simple clinical guide for hospitalization of 
patients with pandemic (H1N1) 2009 infection by using 
results of our multivariate analysis. The presence of any 
of 3 predictors—>2 high-risk medical conditions (includ-
ing age <5 years), dyspnea, or hypoxia—has sensitivity, 
speciﬁ  city, positive predictive value, and negative predic-
tive value of 72%, 88%, 79%, and 83%, respectively, for 
hospitalization. Dyspnea or hypoxia was also predictive of 
ICU admission, with sensitivity, speciﬁ  city, positive pre-
dictive value, and negative predictive value of 94%, 91%, 
71%, 98%, respectively. Identiﬁ  cation of these risk factors 
is widely applicable as a triage tool, especially in settings 
such as physician’s ofﬁ  ces where laboratory and radiologic 
data are not immediately available.
Dr Vasoo is a fellow in the Section of Infectious Diseases at 
Rush University Medical Center. His research interests include 
respiratory pathogens, diagnostic microbiology, and tropical in-
fectious diseases.
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